I am Deputy Vice-Chancellor for Innovation and Commercial Outreach at Karolinska Institutet.
2011-2014, Chairman of the European Institute of Innovation and Technology (EIT) Governing Board. Under my Chairmanship, the EIT has evolved into a high impact innovation investment fund, with a 2.8 Bill € budget and enabled the EIT to implement five further Knowledge and Innovation Communities (KICs) until, 2018, including one to the topic “healthy living & active aging”.
2008-2014 Member of the founding Governing Board of the European Institute of Innovation and Technology (EIT).
2011- re-entered as Member of the Supervisory Board Intercell AG and continue in this position, after the Company has been merged into the biotech enterprise, Valneva, listed in Paris and Vienna 2013.
2007- re-appointed Professor (part leave of absence) of Microbiology at the Max Perutz Laboratories of the University of Vienna and the Medical University.
2007 Chairman of Governing Board the business incubator of the Viennese Universities, initiating more than 140 start-ups since its implementation.
2007-2013 Foreign adjunct Professor at the Karolinska Institutet.
1998-2009 co-founded Intercell AG and led the Company as CEO until it was floated on the Stock Exchange in 2005 and remained as CSO in the Company’s leadership team until 2009.
1993-1998 appointed Professor and Chairman of the Dept. of Microbiology and Genetics at the University of Vienna on the Campus Vienna Biocenter, Austria, where I was engaged to build the public-private partnership between the University of the Vienna and the Institute of Molecular Pathology of Boehringer Ingelheim.
1993-1999 appointed Foreign adjunct Professor at the Karolinska Institutet.
1986-1993 appointed Associate Professor at the Karolinska Institutet.
1982-1986 appointed Associate Professor at the University of Umeå.
1979-1982 Post-doc at the Stanford University.
Ph.D. in Molecular Genetics at the University of Heidelberg in 1978.
A large number of publications, patents, book chapters, and edition of books have documented my passion for biomedical innovation, particularly in the field of microbiology and immunology.
I have been elected member in the editorial board of scientific journals, invited keynote speaker to countless prestigious conferences, meetings, workshops and academic colloquia and co-authored more than 20 patents.
Academic honors, awards and prizes
My achievements have been acknowledged by prestigious industrial awards, academic prizes and honourable memberships, including the Swedish Royal Academy of Engineering Science.